VEGFA and age-related macular degeneration: The introduction of anti-vascular endothelial growth factor (anti-VEGF) intravitreal treatment has provided a significant improvement in visual and anatomical prognosis in patients with neovascular AMD (nAMD), and has resulted in significant reduction of AMD-related irreversible vision loss in developed countries3.